AEF vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AEF exhibits strong fundamental health with a Piotroski F-Score of 7/9 and an extremely attractive valuation, trading at a P/E of 3.84. The stock is significantly undervalued relative to its Graham Number ($19.83) and Intrinsic Value ($67.56), suggesting a massive margin of safety. Despite a bearish technical trend score in the baseline, actual price performance is explosive with a 96.9% 1-year return. The combination of low debt, high ROE (31.21%), and a sustainable 8.07% dividend yield makes this a compelling value play.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
AEF vs JPM: Head-to-Head Comparison
This page compares abrdn Emerging Markets ex-China Fund, Inc. (AEF) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.